Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03182439 · ClinicalTrials.gov registry record · NA

Accuracy of Commercially Available Heart Rate Monitors III

A NA study of Cardiac Rehabilitation, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT03182439 is a NA study of Cardiac Rehabilitation that has completed, run by The Cleveland Clinic. The registered enrollment target is 80 participants, below the 159-participant average among 13 other Cardiac Rehabilitation trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03182439, a NA study of Cardiac Rehabilitation, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to evaluate the accuracy of four heart rate monitors in cardiac rehabilitation patients during typical, supervised cardiac rehabilitation involving exercise on a treadmill and/or stationary bicycle.

Conditions Studied

Interventions

  • DEVICE Apple Watch
  • DEVICE Fit Bit Blaze
  • DEVICE Garmin Forerunner 235
  • DEVICE Tom Tom Spark Cardio

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2017-06-22
Est. Completion 2017-10-11
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT03182439

The ClinicalTrials.gov registry entry for NCT03182439 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 159-participant average among 13 other Cardiac Rehabilitation trials with a reported enrollment target (50% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiac Rehabilitation appearing as the primary indexed condition, and to 4 interventions - of which Apple Watch is the first listed.

NCT03182439 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03182439 about?

NCT03182439 is a clinical study titled "Accuracy of Commercially Available Heart Rate Monitors III". The objective of this study is to evaluate the accuracy of four heart rate monitors in cardiac rehabilitation patients during typical, supervised cardiac rehabilitation involving exercise on a treadmill and/or stationary bicycle.

What is the current status of trial NCT03182439?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2017-06-22. Estimated completion is 2017-10-11.

What conditions does trial NCT03182439 study?

This clinical trial studies the following conditions: Cardiac Rehabilitation.

What interventions are being tested in trial NCT03182439?

The interventions under investigation include: Apple Watch (DEVICE), Fit Bit Blaze (DEVICE), Garmin Forerunner 235 (DEVICE), Tom Tom Spark Cardio (DEVICE).

Who is sponsoring clinical trial NCT03182439?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03182439 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Rehabilitation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.